The most significant breakthrough in reducing smoking-related disease will not come from a new medical treatment. It will come from a fundamental shift in how we approach cessation. For decades, public health messaging has conflated two distinct concepts. These are quitting smoking and quitting nicotine.
Science tells us that while nicotine is addictive, it is not the primary cause of smoking-related disease. The harm comes from combustion. When tobacco burns, it releases thousands of chemicals and over 70 known carcinogens. This toxic smoke is what causes cancer, heart disease and respiratory illness.
Nicotine vs smoke
A useful way to frame this is to distinguish between the active ingredient and the carrier. In smoking, nicotine is the active molecule that consumers seek. The smoke is simply the carrier mechanism. Unfortunately, it is a lethal carrier.
Nicotine itself is not a carcinogen. It does not cause cancer, lung disease or heart disease. Nicotine is a naturally occurring compound found in common vegetables like potatoes and tomatoes. While it can be addictive and not risk-free, its long-term health risks are relatively minor when decoupled from the inhalation of smoke.
However, public perception lags far behind the science. Many people still mistakenly believe that nicotine is the primary cause of smoking-related cancer. This misconception acts as a major barrier. It prevents smokers from switching to safer alternatives because they do not see the point if they believe the risk lies in the nicotine itself.
The failure of the abstinence-only model
Traditional tobacco control often demands total abstinence. It requires a smoker to give up both the ritual of smoking and the chemical dependence on nicotine simultaneously. This is a high barrier to entry for many adults. By insisting on zero nicotine, we inadvertently discourage those who are unable or unwilling to overcome their dependency from seeking safer alternatives.
We need to shift to a model that decouples these two elements. If we allow adult smokers to stop using combustibles without requiring them to eliminate nicotine use, we can dramatically increase success rates.
Real-world data support this approach. New Zealand has actively promoted vaping as a less harmful alternative to smoking. As a result, the country halved its smoking rate from 13.3% in 2018 to 6.9% in 2024. This rapid decline demonstrates that providing a satisfying nicotine alternative is more effective than demand-reduction measures alone.
Sweden offers further proof. The country has the lowest smoking rate in Europe at just 5.6%. This is not because Swedes do not use nicotine. They consume it through snus, which is a smokeless oral product. Consequently, Sweden reports 34% fewer cancer deaths than the European Union average. This data proves that high levels of nicotine consumption can coexist with low levels of smoking-related mortality if the delivery method is non-combustible.
Unlocking health benefits
The goal of public health policy must be the reduction of death and disease. By accepting that some adults will continue to use nicotine, we can pragmatically guide them toward products that reduce their exposure to toxicants by 95% or more.
This approach extends support to a much broader demographic. It offers a lifeline to those who have failed to quit through traditional methods. Decoupling nicotine from smoking unlocks almost all the health and welfare benefits associated with quitting. It saves lives, reduces the burden on healthcare systems and aligns policy with the reality of human behaviour.
